• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Beta-amyloid 25 to 35 is intercalated in anionic and zwitterionic lipid membranes to different extents.β-淀粉样蛋白25至35以不同程度嵌入阴离子和两性离子脂质膜中。
Biophys J. 2002 Nov;83(5):2610-6. doi: 10.1016/S0006-3495(02)75271-5.
2
Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide.脂质膜为阿尔茨海默病β淀粉样肽的有序排列提供模板并诱导其纤维形成。
Proteins. 2008 Jul;72(1):1-24. doi: 10.1002/prot.21887.
3
beta-Sheet structured beta-amyloid(1-40) perturbs phosphatidylcholine model membranes.β-折叠结构的β-淀粉样蛋白(1-40)扰乱磷脂酰胆碱模型膜。
J Mol Biol. 2007 May 11;368(4):982-97. doi: 10.1016/j.jmb.2007.02.063. Epub 2007 Mar 2.
4
Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.阿尔茨海默病淀粉样β肽25 - 35因其与膜的相互作用而抑制脂质过氧化。
Biochem Biophys Res Commun. 1997 Apr 28;233(3):760-4. doi: 10.1006/bbrc.1997.6547.
5
Insertion of externally administered amyloid beta peptide 25-35 and perturbation of lipid bilayers.外部施用的β-淀粉样蛋白肽25-35的插入及脂质双层的扰动。
Biochemistry. 2003 Nov 25;42(46):13667-72. doi: 10.1021/bi035056v.
6
Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.脂质诱导的淀粉样核心片段Abeta(28 - 35)及其A30G和A30I突变体的构象转变。
FEBS J. 2008 May;275(10):2415-27. doi: 10.1111/j.1742-4658.2008.06378.x. Epub 2008 Apr 18.
7
Interaction of a beta-sheet breaker peptide with lipid membranes.β-折叠破坏肽与脂膜的相互作用。
J Pept Sci. 2010 Feb;16(2):115-22. doi: 10.1002/psc.1207.
8
Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions.β-淀粉样肽对脂质膜的破坏作用及金属离子的影响
J Mol Biol. 2006 Feb 24;356(3):759-70. doi: 10.1016/j.jmb.2005.11.091. Epub 2005 Dec 20.
9
The interaction of amyloid Abeta(1-40) with lipid bilayers and ganglioside as studied by 31P solid-state NMR.通过31P固态核磁共振研究淀粉样β蛋白(1-40)与脂质双层和神经节苷脂的相互作用。
Chem Phys Lipids. 2009 Mar;158(1):54-60. doi: 10.1016/j.chemphyslip.2008.12.001. Epub 2008 Dec 24.
10
Interactions of amyloid beta-peptide (1-40) with ganglioside-containing membranes.β-淀粉样肽(1-40)与含神经节苷脂膜的相互作用。
Biochemistry. 1999 Mar 30;38(13):4137-42. doi: 10.1021/bi982345o.

引用本文的文献

1
The influence of a dicationic surfactant on the aggregation process of the IVAGVN peptide derived from the human cystatin C sequence (56-61).一种双阳离子表面活性剂对源自人胱抑素C序列(56-61)的IVAGVN肽聚集过程的影响。
RSC Adv. 2025 Jan 31;15(5):3237-3249. doi: 10.1039/d4ra08377f. eCollection 2025 Jan 29.
2
Polymorphism, Nanostructures, and Barrier Properties of Ceramide-Based Lipid Films.基于神经酰胺的脂质膜的多态性、纳米结构及阻隔性能
ACS Omega. 2022 Dec 23;8(1):422-435. doi: 10.1021/acsomega.2c04924. eCollection 2023 Jan 10.
3
Amyloid-beta peptide (25-35) triggers a reorganization of lipid membranes driven by temperature changes.淀粉样β肽(25-35)触发了由温度变化驱动的脂膜重排。
Sci Rep. 2021 Nov 9;11(1):21990. doi: 10.1038/s41598-021-01347-7.
4
Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology.基于网络药理学的银杏叶治疗神经退行性疾病作用机制研究
Neurochem Res. 2021 Jul;46(7):1881-1894. doi: 10.1007/s11064-021-03315-z. Epub 2021 May 14.
5
De novo aggregation of Alzheimer's Aβ25-35 peptides in a lipid bilayer.阿尔茨海默病 Aβ25-35 肽在双层脂膜中的从头聚集。
Sci Rep. 2019 May 9;9(1):7161. doi: 10.1038/s41598-019-43685-7.
6
Panax ginseng components and the pathogenesis of Alzheimer's disease (Review).人参成分与阿尔茨海默病发病机制的关系(综述)。
Mol Med Rep. 2019 Apr;19(4):2975-2998. doi: 10.3892/mmr.2019.9972. Epub 2019 Feb 19.
7
Interaction of the β amyloid - Aβ(25-35) - peptide with zwitterionic and negatively charged vesicles with and without cholesterol.β淀粉样蛋白(Aβ(25-35))肽与带和不带胆固醇的两性离子和阴离子囊泡的相互作用。
Chem Phys Lipids. 2018 Nov;216:39-47. doi: 10.1016/j.chemphyslip.2018.09.006. Epub 2018 Sep 14.
8
Membrane-Modulating Drugs can Affect the Size of Amyloid-β Aggregates in Anionic Membranes.膜调节药物可以影响阴离子膜中淀粉样β聚集物的大小。
Sci Rep. 2018 Aug 17;8(1):12367. doi: 10.1038/s41598-018-30431-8.
9
Membrane-Accelerated Amyloid-β Aggregation and Formation of Cross-β Sheets.膜加速淀粉样β蛋白聚集及交叉β片层的形成。
Membranes (Basel). 2017 Aug 31;7(3):49. doi: 10.3390/membranes7030049.
10
Intrinsically Disordered Stress Protein COR15A Resides at the Membrane Surface during Dehydration.内在无序应激蛋白COR15A在脱水过程中定位于膜表面。
Biophys J. 2017 Aug 8;113(3):572-579. doi: 10.1016/j.bpj.2017.06.027.

本文引用的文献

1
The presenilins in Alzheimer's disease--proteolysis holds the key.阿尔茨海默病中的早老素——蛋白水解是关键。
Science. 1999 Oct 29;286(5441):916-9. doi: 10.1126/science.286.5441.916.
2
Translating cell biology into therapeutic advances in Alzheimer's disease.将细胞生物学转化为阿尔茨海默病的治疗进展。
Nature. 1999 Jun 24;399(6738 Suppl):A23-31. doi: 10.1038/399a023.
3
Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes.
J Biol Chem. 1999 Jun 25;274(26):18801-7. doi: 10.1074/jbc.274.26.18801.
4
Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.阿尔茨海默病中与胶束结合的淀粉样β-(1-40)和β-(1-42)肽的溶液结构
J Mol Biol. 1999 Jan 15;285(2):755-73. doi: 10.1006/jmbi.1998.2348.
5
Tau in Alzheimer's disease.阿尔茨海默病中的tau蛋白
Trends Cell Biol. 1998 Nov;8(11):425-7. doi: 10.1016/s0962-8924(98)01368-3.
6
Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)].对代表阿尔茨海默病β淀粉样肽[β淀粉样肽(25 - 35)]所谓速激肽样区域的肽段的比较研究。
Biochem J. 1998 Dec 1;336 ( Pt 2)(Pt 2):419-27. doi: 10.1042/bj3360419.
7
Interaction of substance P with phospholipid bilayers: A neutron diffraction study.P物质与磷脂双层的相互作用:一项中子衍射研究。
Biophys J. 1998 Aug;75(2):889-95. doi: 10.1016/S0006-3495(98)77577-0.
8
Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes.阿尔茨海默病β-淀粉样肽(1-40)与脂质膜的相互作用。
Biochemistry. 1997 Dec 2;36(48):14845-52. doi: 10.1021/bi971843e.
9
Alzheimer's disease. The ins and outs of amyloid-beta.阿尔茨海默病。β-淀粉样蛋白的来龙去脉。
Nature. 1997 Oct 16;389(6652):677-8. doi: 10.1038/39479.
10
Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.阿尔茨海默病淀粉样β肽25 - 35因其与膜的相互作用而抑制脂质过氧化。
Biochem Biophys Res Commun. 1997 Apr 28;233(3):760-4. doi: 10.1006/bbrc.1997.6547.

β-淀粉样蛋白25至35以不同程度嵌入阴离子和两性离子脂质膜中。

Beta-amyloid 25 to 35 is intercalated in anionic and zwitterionic lipid membranes to different extents.

作者信息

Dante Silvia, Hauss Thomas, Dencher Norbert A

机构信息

Physical Biochemistry, Darmstadt University of Technology, Petersenstrasse 22, D-64287 Darmstadt, Germany.

出版信息

Biophys J. 2002 Nov;83(5):2610-6. doi: 10.1016/S0006-3495(02)75271-5.

DOI:10.1016/S0006-3495(02)75271-5
PMID:12414694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1302346/
Abstract

Neuronal plasma membranes are thought to be the primary target of the neurotoxic beta-amyloid peptides (Abeta) in the pathogenesis of the Alzheimer's disease. Histologically, Abeta peptides are observed as extracellular macroscopic senile plaques, and most biophysical techniques have indicated the presence of Abeta close to the lipid headgroup region but not in the core of the membrane bilayers. The focus of this study is an investigation of the interaction between Abeta and lipid bilayers from a structural point of view. Neutron diffraction with the use of selectively deuterated amino acids has allowed us to determine unambiguously the position of the neurotoxic fragment Abeta (25-35) in the membrane. Two populations of the peptide are detected, one in the aqueous vicinity of the membrane surface and the second inside the hydrophobic core of the lipid membrane. The location of the C terminus was studied in two different lipid compositions and was found to be dependent on the surface charge of the membrane. The localization of beta-amyloid peptides in cell membranes will offer new insights on their mechanism in the neurodegenerative process associated with Alzheimer's disease and might provide clues for therapeutic developments.

摘要

神经元质膜被认为是阿尔茨海默病发病机制中神经毒性β-淀粉样肽(Aβ)的主要作用靶点。在组织学上,Aβ肽表现为细胞外肉眼可见的老年斑,并且大多数生物物理技术表明Aβ存在于靠近脂质头部基团区域,而非在膜双层的核心部位。本研究的重点是从结构角度研究Aβ与脂质双层之间的相互作用。利用选择性氘代氨基酸进行中子衍射,使我们能够明确确定神经毒性片段Aβ(25 - 35)在膜中的位置。检测到该肽存在两种分布状态,一种在膜表面的水相附近,另一种在脂质膜的疏水核心内部。在两种不同的脂质组成中研究了C末端的位置,发现其依赖于膜的表面电荷。β-淀粉样肽在细胞膜中的定位将为其在与阿尔茨海默病相关的神经退行性过程中的作用机制提供新的见解,并可能为治疗发展提供线索。